MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, FBLG made $5,144,000 in revenue. -$5,778,000 in net income. Net profit margin of -112.33%.

Income Overview

Revenue
$5,144,000
Net Income
-$5,778,000
Net Profit Margin
-112.33%
EPS
-$0.13
Unit: Dollar
Revenue Breakdown
    • Research and development
    • General, administrative and othe...
    • Interest income
    • Change in fair value of sepa put...

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
Research and development
2,789,000 -
General, administrative and other
2,249,000 -
Total operating expenses
5,038,000 -
Loss from operations
-5,038,000 -
Change in fair value of sepa put option liability
33,000 -
Change in fair value of convertible debt
-846,000 -
Other income/(expense)
0 0
Interest income
73,000 -
Interest expense
0 0
Change in fair value of warrant liability
-0
Commitment fee expenses
-0
Total other income/(expense)
-740,000 -
Net loss
-5,778,000 -4,658,000
Net income (loss) attributable to common stockholders
--4,658,000
Net loss per common share attributable to common stockholders, basic
-0.13 -0.12
Net loss per share, diluted
-0.13 -0.12
Weighted-average shares outstanding, basic
43,072,542 38,635,264
Weighted-average shares outstanding, diluted
43,072,542 38,635,264
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$5,778,000 Total otherincome/(expense)-$740,000 Loss from operations-$5,038,000 Interest income$73,000 Change in fair value ofsepa put option...$33,000 Change in fair value ofconvertible debt-$846,000 Total operatingexpenses$5,038,000 General, administrativeand other$2,249,000 Research and development$2,789,000

FibroBiologics, Inc. (FBLG)

FibroBiologics, Inc. (FBLG)